R. Schreiber
Recente publicaties
-
van Veggel, L., Schepers, M., Tiane, A., Kumar, V., Willems, E., Rombaut, B., Noordijk, J., Vangansewinkel, T., Li, A., Wolfs, E., Ozcan, B., Nouboers, E., Moya, P. R., Sauer, D. B., Diliën, H., Hellings, N., Schreiber, R., & Vanmierlo, T. (2025). EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis. Biomedicine & Pharmacotherapy, 186, 117960. Article 117960. https://doi.org/10.1016/j.biopha.2025.117960Meer informative over deze publicatie
-
Magaraggia, I., Krauskopf, J., Ramaekers, J. G., You, Y., de Nijs, L., Briedé, J. J., & Schreiber, R. (2025). Harnessing brain-derived extracellular vesicles to support RDoC-based drug development. Neuroscience Applied, 4, Article 105406. https://doi.org/10.1016/j.nsa.2024.105406Meer informative over deze publicatie
-
van Veggel, L., Voets, A. M., Vanmierlo, T., & Schreiber, R. (2024). Insights from an academic endeavor into central nervous system drug discovery. Neural Regeneration Research, 20(6), 1717-1718. https://doi.org/10.4103/NRR.NRR-D-24-00340Meer informative over deze publicatie
-
van Veggel, L., Mocking, T. A. M., Sijben, H. J., Liu, R., Gonzalez, M. G., Dilweg, M. A., Royakkers, J., Li, A., Kumar, V., Dong, Y. Y., Bullock, A., Sauer, D. B., Dilien, H., van Westen, G. J. P., Schreiber, R., Heitman, L. H., & Vanmierlo, T. (2024). Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake Assays. Acs Chemical Neuroscience, 15(7), 1424-1431. https://doi.org/10.1021/acschemneuro.3c00731Meer informative over deze publicatie
-
van Veggel, L., Schepers, M., Tiane, A., Rombaut, B., Royakkers, J., Dilien, H., Hellings, N., Moya, P., Schreiber, R., & Vanmierlo, T. (2023). EAAT3 modulation of the oligodendrocyte lineage in in vitro and in vivo models of Multiple Sclerosis. Glia, 71, E721-E721.Meer informative over deze publicatie
-
Huisman, G., Menke, M., Grundmann, O., Schreiber, R., & Mason, N. (2023). Examining the Psychoactive Differences between Kratom Strains. International Journal of Environmental Research and Public Health, 20(14), Article 6425. https://doi.org/10.3390/ijerph20146425Meer informative over deze publicatie
-
Klaas, S., Siva, J. B., Bak, M., Govers, M., & Schreiber, R. (2023). The pathophysiology of Post SSRI Sexual Dysfunction: Lessons from a case study. Biomedicine & Pharmacotherapy, 161(1), Article 114166. https://doi.org/10.1016/j.biopha.2022.114166Meer informative over deze publicatie
-
Zalm, P. W. V., Ahmed, S., Fatou, B., Schreiber, R., Barnaby, O., Boxer, A., Zetterberg, H., Steen, J. A., & Steen, H. (2023). Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers. Cell Reports Medicine, 4(4), Article 101005. https://doi.org/10.1016/j.xcrm.2023.101005Meer informative over deze publicatie
-
Kong, L., He, Q., Li, Q., Schreiber, R., Kaitin, K. I., & Shao, L. (2023). Rapid progress in neuroimaging technologies fuels central nervous system translational medicine. Drug Discovery Today, 28(3), Article 103485. https://doi.org/10.1016/j.drudis.2023.103485Meer informative over deze publicatie
-
Schreiber, R., Campbell, U., Quinton, M. S., Hardy, L. W., Fang, Q. K., & Lew, R. (2022). In vitro and in vivo pharmacological characterization of dasotraline, a dual dopamine and norepinephrine transporter inhibitor in vivo. Biomedicine & Pharmacotherapy, 153, Article 113359. https://doi.org/10.1016/j.biopha.2022.113359Meer informative over deze publicatie